An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Investigational Treatment Acquiring Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to contact these accounts directly for source information, while also obtaining promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on messaging services, where groups with thousands of participants share comparison images, injection guides and assertions of rapid British shipping. Sellers market the substance there before redirecting customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Experts Voice Worries
However, physicians and chemists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could result in users injecting products of uncertain source.
Several experts stated the demand for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.
Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.
Service Response and Content Removal
According to TikTok, the platform has removed violative content and prohibited associated keywords and query recommendations. The company stated it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.
Digital Marketplace Activities
Investigations also found groups with up to nine thousand members selling retatrutide using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, populated with photos of weight loss, glowing reviews and step-by-step guides for mixing or injecting at residence.
After moments of entering one group, a vendor posted contact information, where the majority of purchases occur. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.
Product Information and Costs
Within these communities, messages show dark colored parcels with Royal Mail labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for the messaging service said it actively moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering substances they can’t verify. Even if the research behind this drug is valid, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of an online medical service connected the increase in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.
Her team has previously encountered individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject users to possibly serious health risks”.
